Twin Tree Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-357
Closed -$87K 1614
2025
Q1
$87K Buy
+357
New +$107K ﹤0.01% 1424
2024
Q1
Sell
-28,402
Closed -$9.34M 1277
2023
Q4
$9.17M Buy
+28,402
New +$8.9M 0.02% 712
2023
Q1
Sell
-1,727
Closed -$726K 1284
2022
Q4
$726K Buy
+1,727
New +$697K ﹤0.01% 1072
2021
Q4
Sell
-1,392
Closed -$1.04M 1588
2021
Q3
$1.04M Buy
+1,392
New +$1.04M ﹤0.01% 1178
2020
Q2
Sell
-19
Closed -$7K 1461
2020
Q1
$7K Sell
19
-4,941
-100% -$1.82M ﹤0.01% 1270
2019
Q4
$1.83M Sell
4,960
-3,290
-40% -$1.16M 0.01% 745
2019
Q3
$2.75M Buy
8,250
+3,679
+80% +$1.2M 0.01% 617
2019
Q2
$1.43M Sell
4,571
-22,487
-83% -$6.73M 0.01% 727
2019
Q1
$8.27M Buy
27,058
+23,644
+693% +$6.38M 0.04% 339
2018
Q4
$793K Buy
+3,414
New +$916K ﹤0.01% 903
2018
Q2
Sell
-4,999
Closed -$1.25M 1142
2018
Q1
$1.25M Sell
4,999
-1,467
-23% -$374K 0.01% 622
2017
Q4
$1.54M Buy
+6,466
New +$1.57M 0.01% 635

Other funds holding BIO

Twin Tree Management's BIO Position: Q2 2025 in Review

Twin Tree Management sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2025, closing a stake of 357 shares — an estimated $87K sold.

Twin Tree Management first reported a position in BIO in Q4 2017 and held it in 12 quarters. The position peaked at $9.17M in Q4 2023. 384 funds tracked by Wall St. Rank hold BIO as of Q2 2025.

  • Twin Tree Management reported no remaining Bio-Rad Laboratories Class A position as of Q2 2025 after selling out during the quarter.
  • Twin Tree Management sold 357 Bio-Rad Laboratories Class A shares in Q2 2025, an estimated $87K.
  • Twin Tree Management first reported a position in Bio-Rad Laboratories Class A in Q4 2017 and held it in 12 quarters.
  • Twin Tree Management's Bio-Rad Laboratories Class A position peaked at $9.17M in Q4 2023.
  • 384 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2025.

Based on Twin Tree Management's 13F filing for Q2 2025, filed 28 Jul 2025.